Clarkson's study of the locomotor effects of the drug RTI-55 inspired Dr. James H. Heym, director of Pfizer's Department of Neuroscience and General Pharmocology to say to Clarkson, "We have an actice program in the pharmocology addiction and your study in the behavioral effects of RTI-55 fits with our interests.

Clarkson said Pfizer will provide a grant of $1,834.15 to complete his work. Heym also told Clarkson, "At the completion of your research project you might consider a visit to Pfizer Central Research to discuss the results of your research with some of our scientists."

Clarkson said his research thus far has led him to believe that RTI-55 may not be effective in treating cocaine use.

"But I am happy as an undergraduate to receive such a grant," Clarkson said. "It will allow me to finish the project."

Clarkson will be going to Mongolia this summer to teach English, and in the fall will be at Harvard University doing research in the field of neuroscience. Clarkson was an E.B. Kennedy Scholar at Erskine.